TRACY MOORE DUARTE: Open Payments
NPI 1679145981 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 120 payments from 13 companies in 2025. Trend: 2023 $2,031 · 2024 $1,605 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $466 |
| Lundbeck LLC | 19 | $222 |
| Teva Pharmaceuticals USA, Inc. | 21 | $197 |
| Alkermes, Inc. | 9 | $191 |
| E.R. Squibb & Sons, L.L.C. | 9 | $187 |
| ABBVIE INC. | 18 | $157 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: CAPLYTA, REXULTI, ARISTADA, COBENFY, VRAYLAR, AUSTEDO XR, FANAPT, INGREZZA.
Industry payments across VA — which companies pay providers there.
